(Q43833541)

27 November 2017

title

Lutein and zeaxanthin for macular degeneration (English)

1 reference

27 November 2017

Lili Zhao

1

1 reference

27 November 2017

Burgunda V Sweet

series ordinal

2

1 reference

27 November 2017

publication date

1 July 2008

1 reference

American Journal of Health-System Pharmacy

27 November 2017

published in

1 reference

27 November 2017

volume

65

1 reference

27 November 2017

issue

13

1 reference

27 November 2017

page(s)

1232-1238

1 reference

Serum levels of macular carotenoids in relation to age-related maculopathy: the Muenster Aging and Retina Study (MARS).

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.2146%2FAHJP080052

Consumption of one egg per day increases serum lutein and zeaxanthin concentrations in older adults without altering serum lipid and lipoprotein cholesterol concentrations

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAHJP080052

Lutein and zeaxanthin in the diet and serum and their relation to age-related maculopathy in the third national health and nutrition examination survey

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAHJP080052

The effect of lutein and zeaxanthin supplementation on metabolites of these carotenoids in the serum of persons aged 60 or older.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAHJP080052

A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAHJP080052

The Framingham Eye Study. I. Outline and major prevalence findings

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAHJP080052

Predictors of optical density of lutein and zeaxanthin in retinas of older women in the Carotenoids in Age-Related Eye Disease Study, an ancillary study of the Women's Health Initiative

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAHJP080052

The relationships between macular pigment optical density and its constituent carotenoids in diet and serum.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAHJP080052

Risk factors associated with age-related macular degeneration. A case-control study in the age-related eye disease study: Age-Related Eye Disease Study Report Number 3

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAHJP080052

Changes in macular pigment optical density and serum concentrations of its constituent carotenoids following supplemental lutein and zeaxanthin: the LUNA study

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAHJP080052

Dose-Ranging Study of Lutein Supplementation in Persons Aged 60 Years or Older

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAHJP080052

Biologic mechanisms of the protective role of lutein and zeaxanthin in the eye.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAHJP080052

Xanthophyll accumulation in the human retina during supplementation with lutein or zeaxanthin - the LUXEA (LUtein Xanthophyll Eye Accumulation) study.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAHJP080052

Macular pigments lutein and zeaxanthin as blue light filters studied in liposomes

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAHJP080052

Lutein and zeaxanthin as protectors of lipid membranes against oxidative damage: the structural aspects.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAHJP080052

Long term dietary supplementation with zeaxanthin reduces photoreceptor death in light-damaged Japanese quail

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAHJP080052

Protective effects of various antioxidants during ischemia-reperfusion in the rat retina

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAHJP080052

Absorption, metabolism, and transport of carotenoids.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAHJP080052

Macular pigment optical density and its relationship with serum and dietary levels of lutein and zeaxanthin.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAHJP080052

Hydrolysis of zeaxanthin esters by carboxyl ester lipase during digestion facilitates micellarization and uptake of the xanthophyll by Caco-2 human intestinal cells

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAHJP080052

Kinetics of gastro-intestinal transit and carotenoid absorption and disposal in ileostomy volunteers fed spinach meals

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAHJP080052

Plasma kinetics of zeaxanthin and 3'-dehydro-lutein after multiple oral doses of synthetic zeaxanthin

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAHJP080052

Effect of dietary lutein and zeaxanthin on plasma carotenoids and their transport in lipoproteins in age-related macular degeneration

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAHJP080052

Kinetics of 14C distribution after tracer dose of 14C-lutein in an adult woman.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAHJP080052

Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. Eye Disease Case-Control Study Group

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAHJP080052

Neovascular age-related macular degeneration and its relationship to antioxidant intake

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAHJP080052

Plasma lutein and zeaxanthin and other carotenoids as modifiable risk factors for age-related maculopathy and cataract: the POLA Study

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAHJP080052

Lutein and zeaxanthin status and risk of age-related macular degeneration.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAHJP080052

Serum Antioxidants and Age-Related Macular Degeneration in a Population-Based Case-Control Study

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAHJP080052

Dietary antioxidant intake and incidence of early age-related maculopathy: the Blue Mountains Eye Study

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAHJP080052

Lycopene but not lutein nor zeaxanthin decreases in serum and lipoproteins in age-related macular degeneration patients.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAHJP080052

Associations Between Intermediate Age-Related Macular Degeneration and Lutein and Zeaxanthin in the Carotenoids in Age-Related Eye Disease Study (CAREDS)

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAHJP080052

Nutritional manipulation of primate retinas, I: effects of lutein or zeaxanthin supplements on serum and macular pigment in xanthophyll-free rhesus monkeys.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAHJP080052

Lutein, zeaxanthin, macular pigment, and visual function in adult cystic fibrosis patients

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAHJP080052

Relation between dietary intake, serum concentrations, and retinal concentrations of lutein and zeaxanthin in adults in a Midwest population

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAHJP080052

Diet and serum carotenoid concentrations affect macular pigment optical density in adults 45 years and older.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAHJP080052

Plasma and macular responses to lutein supplement in subjects with and without age-related maculopathy: a pilot study

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAHJP080052

The effects of supplementation with lutein and/or zeaxanthin on human macular pigment density and colour vision.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAHJP080052

Supplementation with the carotenoids lutein or zeaxanthin improves human visual performance.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAHJP080052

Double-masked, placebo-controlled, randomized trial of lutein and antioxidant supplementation in the intervention of atrophic age-related macular degeneration: the Veterans LAST study (Lutein Antioxidant Supplementation Trial).

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAHJP080052

The body of evidence to support a protective role for lutein and zeaxanthin in delaying chronic disease. Overview

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAHJP080052

Lutein and zeaxanthin concentrations in plasma after dietary supplementation with egg yolk

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAHJP080052

Lutein and zeaxanthin dietary supplements raise macular pigment density and serum concentrations of these carotenoids in humans.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAHJP080052

Lutein and zeaxanthin intakes and risk of age-related macular degeneration and cataracts: an evaluation using the Food and Drug Administration's evidence-based review system for health claims

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAHJP080052

31 March 2020

Identifiers

DOI

10.2146/AHJP080052

1 reference

27 November 2017

1 reference